Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
89,506,929
-
Total 13F shares
-
34,138,461
-
Share change
-
+22,320,755
-
Total reported value
-
$68,276,752
-
Put/Call ratio
-
243%
-
Price per share
-
$2.00
-
Number of holders
-
61
-
Value change
-
+$44,826,873
-
Number of buys
-
44
-
Number of sells
-
11
Institutional Holders of Milestone Pharmaceuticals Inc. - Common Stock (MIST) as of Q3 2025
As of 30 Sep 2025 Milestone Pharmaceuticals Inc. - Common Stock (MIST) had 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,138,461 shares of stock of the company.
Largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., Propel Bio Management, LLC, ORBIMED ADVISORS LLC, MORGAN STANLEY, Simplify Asset Management Inc., RTW INVESTMENTS, LP, Pathstone Holdings, LLC, SPHERA FUNDS MANAGEMENT LTD., TORONTO DOMINION BANK, and Boxer Capital Management, LLC.
This table shows 61 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.